Posted On: 02/02/2014 11:30:25 AM
Post# of 63761
$VNDA new climber at resistance $13.23
Shares Outstanding 33,190,106 a/o Oct 31, 2013
Float Not Available
FDA Approves Vanda's Hetlioz To Treat Sleep Disorder In Fully Blind Individuals
2/1/2014 2:07:00 PM - RTT News
FDA Approves HETLIOZ™ (tasimelteon) for the Treatment of Non-24-Hour Sleep-Wake Disorder
1/31/2014 1:45:00 PM - PR Newswire
Vanda Pharmaceuticals to Announce Fourth Quarter 2013 Financial Results on February 13, 2014
1/23/2014 5:00:00 PM - PR Newswire
Immunomedics (IMMU) Jumps: Stock Adds 10.3% in Session - Tale of the Tape
1/2/2014 9:25:01 AM - Zacks.com
Peregrine Pharma Initiates Bavituximab Study - Analyst Blog
12/31/2013 5:20:01 PM - Zacks.com
Shares Outstanding 33,190,106 a/o Oct 31, 2013
Float Not Available
FDA Approves Vanda's Hetlioz To Treat Sleep Disorder In Fully Blind Individuals
2/1/2014 2:07:00 PM - RTT News
FDA Approves HETLIOZ™ (tasimelteon) for the Treatment of Non-24-Hour Sleep-Wake Disorder
1/31/2014 1:45:00 PM - PR Newswire
Vanda Pharmaceuticals to Announce Fourth Quarter 2013 Financial Results on February 13, 2014
1/23/2014 5:00:00 PM - PR Newswire
Immunomedics (IMMU) Jumps: Stock Adds 10.3% in Session - Tale of the Tape
1/2/2014 9:25:01 AM - Zacks.com
Peregrine Pharma Initiates Bavituximab Study - Analyst Blog
12/31/2013 5:20:01 PM - Zacks.com
(0)
(0)Scroll down for more posts ▼
